QurCan Therapeutics
PrivateLast Round
Accelerator
Oct 5, 2022
Total Funding Raised
$6.15M
Company Overview
QurCan Therapeutics is a biotechnology company that develops a proprietary nanoparticle drug delivery platform for targeted therapeutics to treat cancer and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Advanced Materials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
QurCan Therapeutics Comparables
Compare QurCan Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nanite, Inc. | 86% | |
| CereCura Nanotherapeutics | 84% | |
| Nosis Bio | 79% | |
QurCan Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Oct 5, 2022 | ||||
| Grant | Sep 1, 2022 | ||||
| Seed | May 17, 2021 | ||||
| Seed | Jan 28, 2020 | ||||
| Seed | Apr 8, 2019 | ||||
Grant | Mar 21, 2019 |
QurCan Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ontario Brain Institute | Grant, Seed |
| MEDTEQ+ | Seed |
| Mission BioCapital | Accelerator |
| National Research Council of Canada | Grant |
| Pfizer | Accelerator |
| FACIT | Seed |
| Ontario Centre of Innovation | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2022
$76K grant received from National Research Council of Canada.
- May 17, 2021
$3M round led by FACIT
QurCan Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about QurCan Therapeutics's valuation, stock price, and market status.